We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
+11.4%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$361M
AUM Growth
+$13.5M
Cap. Flow
+$2.7M
Cap. Flow %
0.75%
Top 10 Hldgs %
38.32%
Holding
92
New
22
Increased
23
Reduced
17
Closed
21

Top Buys

Rank Stock Value
1
MCK icon
McKesson
MCK
+$12.1M
2
CNC icon
Centene
CNC
+$9.16M
3
BIIB icon
Biogen
BIIB
+$9M
4
ABT icon
Abbott
ABT
+$8.96M
5
AMED
Amedisys
AMED
+$8.04M

Top Sells

Rank Stock Value
1
ARNA
Arena Pharmaceuticals Inc
ARNA
+$17.9M
2
MDT icon
Medtronic
MDT
+$10M
3
HOLX
Hologic
HOLX
+$8.86M
4
ZBH icon
Zimmer Biomet
ZBH
+$8.78M
5
ACHC icon
Acadia Healthcare
ACHC
+$8.05M

Sector Composition

Rank Sector Weight
1 Healthcare 97.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AZN icon
26
AstraZeneca
AZN
$249B
$5.83M 1.61%
+50,000
New +$5.88M
APLS
27
DELISTED
Apellis Pharmaceuticals
APLS
$5.67M 1.57%
120,000
-70,000
-37% -$2.76M
ONEM
28
DELISTED
1Life Healthcare
ONEM
$4.83M 1.34%
+275,000
New +$5.33M
IRTC icon
29
iRhythm Holdings
IRTC
$4.01B
$4.71M 1.3%
+40,000
New +$3.67M
DNLI icon
30
Denali Therapeutics
DNLI
$3.96B
$4.46M 1.23%
100,000
+25,000
+33% +$1.18M
GSK icon
31
GSK
GSK
$103B
$4.41M 1.22%
+80,000
New +$4.16M
BMRN icon
32
BioMarin Pharmaceuticals
BMRN
$13.4B
$4.24M 1.17%
48,000
+30,000
+167% +$2.48M
SIBN icon
33
SI-BONE Inc
SIBN
$850M
$3.89M 1.08%
175,000
+5,000
+3% +$108K
ALNY icon
34
Alnylam Pharmaceuticals
ALNY
$29.2B
$3.39M 0.94%
20,000
-5,000
-20% -$929K
AGL icon
35
Agilon Health
AGL
$1.59B
$3.38M 0.93%
5,000
-2,200
-31% -$1.34M
ARWR icon
36
Arrowhead Research
ARWR
$12.6B
$3.31M 0.92%
+50,000
New +$3.44M
HZNP
37
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.23M 0.89%
30,000
-30,000
-50% -$3.27M
ATRA icon
38
Atara Biotherapeutics
ATRA
$76.2M
$3.15M 0.87%
8,000
– –
MASI
39
DELISTED
Masimo
MASI
$2.93M 0.81%
+10,000
New +$2.85M
ACRS icon
40
Aclaris Therapeutics
ACRS
$858M
$2.91M 0.8%
200,000
+15,000
+8% +$227K
NVRO
41
DELISTED
NEVRO CORP.
NVRO
$2.84M 0.79%
35,000
+5,000
+17% +$501K
AVTX icon
42
Avalo Therapeutics
AVTX
$1.04B
$2.76M 0.76%
564
– –
RETA
43
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$2.72M 0.75%
103,000
+68,000
+194% +$5.26M
REPL icon
44
Replimune Group
REPL
$1.13B
$2.71M 0.75%
100,000
+10,000
+11% +$299K
BBIO icon
45
CALL
BridgeBio Pharma
BBIO
$16.6B
$2.5M 0.69%
+150,000
New +$6.35M
RGNX icon
46
Regenxbio
RGNX
$681M
$2.45M 0.68%
75,000
+20,000
+36% +$681K
ARCT icon
47
Arcturus Therapeutics
ARCT
$215M
$2.41M 0.67%
65,000
-20,000
-24% -$815K
ITOS
48
DELISTED
iTeos Therapeutics
ITOS
$2.33M 0.64%
+50,000
New +$1.66M
INCY icon
49
Incyte
INCY
$24.4B
$2.2M 0.61%
+30,000
New +$2.02M
INSM icon
50
Insmed
INSM
$29.4B
$2.18M 0.6%
80,000
-20,000
-20% -$572K
1
2
3 4

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return

Integral Health Asset Management's Q4 2021 Portfolio in Review

As of Q4 2021, Integral Health Asset Management held 92 positions worth $361M, up 3.9% from $348M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Integral Health Asset Management's Q4 2021 filing shows 22 new, 23 increased, 17 reduced and 21 closed positions. Its largest new stake was McKesson: 55,000 shares worth $13.7M. The largest sale was Arena Pharmaceuticals Inc, an estimated $17.9M.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, down from 98% a quarter earlier.

  • Integral Health Asset Management's largest Q4 2021 buy was McKesson: 55,000 shares worth $13.7M.
  • Integral Health Asset Management added most to Centene in Q4 2021, an estimated $9.16M increase.
  • Integral Health Asset Management's biggest Q4 2021 reduction was Acadia Healthcare, cutting an estimated $8.05M.
  • Integral Health Asset Management fully exited Arena Pharmaceuticals Inc in Q4 2021, selling an estimated $17.9M.
  • Integral Health Asset Management's ten largest holdings make up 38% of its $361M portfolio in Q4 2021.
  • Integral Health Asset Management opened 22 new positions and closed 21 in Q4 2021.
  • Integral Health Asset Management's portfolio value rose 3.9% quarter-over-quarter to $361M.

Based on Integral Health Asset Management's 13F filing for Q4 2021, filed 2 Feb 2022.